U.S. Purchases Additional COVID Treatment from Lilly
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the federal government has purchased 388,000 additional doses of its antibody therapy etesevimab, which is used in conjunction with bamlanivimab a... Read More